185946-04-7

Basic information

• Product Name: Benzonitrile, 3-fluoro-4-(methylthio)-
• CAS NO: 185946-04-7
• Molecular Formula: C8H6FNS
• Molecular Weight: 167.207
• Mol File: 185946-04-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 3-fluoro-4-(methylthio)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 3-fluoro-4-(methylthio)-(185946-04-7)
• EPA Substance Registry System: Benzonitrile, 3-fluoro-4-(methylthio)-(185946-04-7)

Safety Data

• Hazardous Substances Data: 185946-04-7(Hazardous Substances Data)

Upstream product

• 64248-62-0 3,4-Difluorobenzonitrile 
• 5188-07-8 sodium thiomethoxide 

Downstream Products

• 918967-78-9 4-cyano-2-fluorobenzene-1-sulfonyl chloride 
• 1263320-97-3 3-[3-fluoro-4-(methylsulfonyl)phenyl]-5-{(1R)-1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,2,4-oxadiazole 
• 1263320-99-5 5-ethyl-3-(4-{[(1R)-1-{3-[3-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propyl]oxy}phenyl)-1,2,4-oxadiazole 
• 185946-05-8 3-Fluoro-4-methylsulfonylbenzonitrile 
• 1263320-48-4 3-fluoro-N'-hydroxy-4-(methylsulfonyl)benzenecarboximidamide 
• 1263320-67-7 3-[3-fluoro-4-[methylsulfonyl]phenyl]-5-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,2,4-oxadiazole 
• 1570084-22-8 3-fluoro-4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamine 
• 1570084-27-3 2-(3-fluoro-4-(N-cyano-S-(methyl)sulfonimidoyl)benzyl)isoindole-1,3-dione 
• 1569652-12-5 2-(3-fluoro-4-methylsulfanyl-benzyl)-isoindole-1,3-dione 
• 918967-58-5 3-fluoro-N-hydroxy-4-sulfamoylbenzamidine 
• 1569648-33-4 1-isopropyl-6-methyl-4-oxo-5-(3-trifluoromethyl-phenyl)-1,4-dihydro-pyridine-3-carboxylic acid 3-fluoro-4-methanesulfonyl-benzylamide 
• 1570084-25-1 2-(3-fluoro-4-(N-cyano-S-methylsulfinimidoyl )-benzyl)-isoindole-1,3-dione 
• 1425092-76-7 1-(3-fluoro-4-methanesulfonylphenyl)methanamine 

Relevant articles and documents

SULFONE DERIVATIVE

Provided are a compound having an excellent hypoglycemic action, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the

HETEROCYCLIC GPCR AGONISTS

Compounds of formula (I) or pharmaceutically acceptable salts thereof, are agonists of GPR119 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.